These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A new culture system for the cultivation of mammalian cells for the production of several biologically active substances.
    Author: Murata M, Togami M, Tawara Y, Onodera K.
    Journal: Cytotechnology; 1993; 13(2):143-8. PubMed ID: 7764579.
    Abstract:
    We recently developed a new dialysis culture system (termed LIFROC-device) for the cultivation of lymphokine-activated killer cells (Murata et al., 1990, 1991). In the present study, we applied the LIFROC-device (400 ml culture vessel) to the cultivation of mammalian cells for the production of biologically active substances. We cultured mouse-mouse hybridoma TP-709, secreting anti-tisse plasminogen activator (tPA) monoclonal antibody (mAb), recombinant CHO GT19, secreting hGH, and human melanoma Bowes cells, secreting tPA. With the LIFROC-device, TP-709 grew to a maximal cell density of 3.8 x 10(6) cells/ml and and produced 480 micrograms/ml (192 mg in total) of mAb. GT19 reached a cell density of 2.2 x 10(6) cells/ml and produced 302 micrograms/ml (120 mg in total) of hGH. Bowes cells expanded to 4.4 x 10(6) cells/ml and secreted 8.5 micrograms/ml (3.3 mg in total) of tPA. The protein concentration in the culture broths of the LIFROC-device became 7-200 times higher than that of batch culture. Thus, the LIFROC-device can be applied to protein production as well as cell growth with high efficiency.
    [Abstract] [Full Text] [Related] [New Search]